
PECULIARITIES OF THE ANTIAPOPTOTIC BCL-2 PROTEIN EXPRESSION IN LIVER IN A MODEL OF OBESITY AND TYPE 2 DIABETES AND WITH LINAGLYPTIN CORRECTION
Author(s) -
M. A. Cherepanova,
Experimental Lymphology
Publication year - 1993
Publication title -
acta biomedica scientifica
Language(s) - English
Resource type - Journals
eISSN - 2587-9596
pISSN - 2541-9420
DOI - 10.29413/abs.2018-3.1.18
Subject(s) - apoptosis , cirrhosis , type 2 diabetes , fatty liver , type 2 diabetes mellitus , diabetes mellitus , steatohepatitis , medicine , placebo , obesity , endocrinology , immunohistochemistry , nonalcoholic fatty liver disease , disease , cancer research , pathology , chemistry , biochemistry , alternative medicine